Galderma Group AG (XSWX:GALD) EV-to-FCF : 128.15 (As of Apr. 03, 2025)

Galderma Group AG EV-to-FCF Chart

Competitive Comparison of Galderma Group AG's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's EV-to-FCF falls into.

Galderma Group AG EV-to-FCF Calculation

Galderma Group AG's EV-to-FCF for today is calculated as:

Galderma Group AG's current Enterprise Value is CHF24,326 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Galderma Group AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was CHF190 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG  (XSWX:GALD) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Galderma Group AG's PE Ratio (TTM) for today is calculated as:

Galderma Group AG's share price for today is CHF93.89.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Galderma Group AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was CHF0.866.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Galderma Group AG EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description